{"name":"Panbela Therapeutics","slug":"panbela","ticker":"PBLA","exchange":"NASDAQ","domain":"panbela.com","description":"Panbela Therapeutics (PBLA) is a biopharmaceutical company focused on developing innovative treatments for pancreatic cancer. The company's lead product candidate, PB1046, is an oral formulation of gemcitabine, a standard-of-care chemotherapy for pancreatic cancer. Panbela Therapeutics is a relatively small company with a limited market presence in the oncology space.","hq":"Waconia, MN","founded":0,"employees":"","ceo":"Jennifer K. Simpson","sector":"Oncology / Pancreatic Cancer","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$35M","metrics":{"revenue":1356995,"revenueGrowth":39.3,"grossMargin":0,"rdSpend":20614000,"netIncome":-25263000,"cash":11802000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2014"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-28","type":"earnings","headline":"Panbela Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results","summary":"Panbela Therapeutics reported its financial results for the fourth quarter and full year 2022, with a net loss of $13.4 million for the year.","drugName":"","sentiment":"neutral"},{"date":"2022-06-30","type":"trial","headline":"Panbela Therapeutics Announces Update on Phase 3 Clinical Trial of PB1046","summary":"Panbela Therapeutics announced an update on its Phase 3 clinical trial of PB1046, with the trial continuing to enroll patients.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5YQ3pYeTV2cFJhQzlIbW16Yzl5Ujd5MWNmMS1ldHUzXzZsOXoxbGJNYUkzVmczdEttcXBUNmkyaGhCbE90TXpONXJtdzM3bDE0ZDZB?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"VINC Stock Price, News & Analysis | Vincerx Pharma - Stock Titan","headline":"VINC Stock Price, News & Analysis | Vincerx Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9LUkFvZkFXQWhoUHQ1ZW1tTFlfRGEtaXlYTlhIVl83NXJjV1l3LWZoelV1OHE1Nk1paUVOdndWUWxaVzFnOTNiRGZQdjIxM2ticU1n?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"VIRX Stock Price, News & Analysis - Stock Titan","headline":"VIRX Stock Price, News & Analysis","sentiment":"neutral"},{"date":"2025-02-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-02-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-01-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2024-11-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNVnVCRVk2X1Q3b2lPT1JROUVuQkFfd0xPcmNEZ2oydUNrRDNTUlE5Q3NTOWdDbkthNWxNNWpYVTE2MUI3eEVNVjU1SkMwcXNNQXptU2VwWl9SN2w2UWF3TlBscVVLWDRNUXhSNzlMX2lvU3NLQkJBV3JDSzNIRVZ2QWVYV0NSYWxlYkpzWnJhbU5YcnZyT01UcTFqMERDS0djRm1pcndaWjlYdXZieVVYZ08wZHhUTTM3?oc=5","date":"2024-08-13","type":"earnings","source":"Stock Titan","summary":"Panbela Provides Business Update and Reports Q2 2024 Financial Results - Stock Titan","headline":"Panbela Provides Business Update and Reports Q2 2024 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9YakNzTzlWbHVVaUF1QmREeFVEUDlhNndXTllCU3JHQTNGYzNLbndmQUFHbUNRYWxpUkVOVnZwU0tyZDBEbXFJRUpYZGxtV3JRNUdlQjFMNDg?oc=5","date":"2024-03-09","type":"pipeline","source":"TradingView","summary":"PBLA Stock Price and Chart — OTC:PBLA - TradingView","headline":"PBLA Stock Price and Chart — OTC:PBLA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNaTdrZmRweF9Ua0k5X1Bfb0JlMWNELTFYSmpSY0I0cE5GUXg2T2I3a1Z6a1JBRFVaVGpQNFVVcXphU1F5dEZScHhLZkNvX3JPM3M0dThGNUdlQ3hyRXk0VWNUb0d4bXQ2UnJNdzFSLVFxZ3psQnpGNXlaZkRxaVNpazVkdEVIalRHbzE1UFgtV0ZCNDE2YkdXMjlWc2hsbXZDS3daZjEtY3J1WUEwMS1nb2NvU2tVam15Y2Y0RU5WNE53R3p4SEI1T09rdkVMQXhrSVNHOUZ1c1pmM3hsREhuMVhmVUFsYUp3RDZET1F6bWg3Zw?oc=5","date":"2022-06-16","type":"pipeline","source":"globenewswire.com","summary":"Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc. - globenewswire.com","headline":"Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1MZVlyUXF1WUxLZzdtRzJUdjlxaC1GNjNDQ0NWR0xMWmRSMWhBelJkb3oxVGxrekY5S1ZRai04LVlMVDFtbXN3UTdFSWJNZzIyMjROc1ZfcGRnSk9ySmc?oc=5","date":"2021-02-10","type":"pipeline","source":"Stock Titan","summary":"Latest PBLA News - Panbela Provides Update on Current Clinical... - Stock Titan","headline":"Latest PBLA News - Panbela Provides Update on Current Clinical...","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Celgene","Bayer","Merck"],"therapeuticFocus":["Oncology","Pancreatic Cancer"],"financials":{"source":"sec_edgar+yahoo","revenue":1356995,"revenuePeriod":"2014-12-31","revenueHistory":[{"value":1356995,"period":"2014-12-31"},{"value":973813,"period":"2013-12-31"},{"value":973813,"period":"2013-12-31"},{"value":1232704,"period":"2012-12-31"},{"value":1232704,"period":"2012-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":20614000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-25263000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":11802000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}